

Session 4: Biotech Due Diligence, Valuation & Risk Assessment. Megha Unhelkar, PhD; Director, Bioscience Investments, CT Innovations
Registration
About Event
Learn how to evaluate deals and understand uncertainties. Build investor skillsets including due diligence, and financial valuation.
Location